Global Platelet-rich Plasma Market is expected to grow at a CAGR of 12.21% during the forecast period from 2018-2025
A new research report published by Fior Markets with the title Global Platelet-rich Plasma Market by Type (Pure Platelet-rich Plasma, Leukocyte-rich Platelet-rich Plasma, Pure Platelet-rich Fibrin) Origin, Application, and Region and Global Forecast 2018-2025.
As per the report, the global platelet-rich plasma market is expected to grow from USD 197.27 Million in 2017 to USD 540.31 Million by 2025 at a CAGR of 12.21% during the forecast period from 2018-2025. North America has captured the largest market share and generating the highest revenue during the forecast period. High prevalence of orthopedic diseases, increase in demand for cosmetic surgeries, approvals of various products by the U.S. FDA and surge in awareness among the patient population are boosting the growth of the market.
DOWNLOAD FREE SAMPLE REPORT: https://www.fiormarkets.com/report-detail/375984/request-sample
Major players operating in the market are Harvest Technologies Corp, Arthrex, Inc., Zimmer Biomet Holdings, Inc., EmCyte Corporation, Regen Lab SA, Exactech, Inc., Cesca Therapeutics, Inc., Nuo Therapeutics, Inc., DePuy Synthes, ISTO Biologics, AdiStem Ltd and others. Extensive product portfolio and expansion strategies by major players are contributing for the growth of the sector. For instance, in November 2017, The Cascade Medical’s designed FIBRINETSystem received FDA approval, which is used for the safe and rapid preparation of autologous platelet-rich plasma (PRP) from a small sample of blood at the patient point of care in the United States.
rich Plasma, Pure Platelet-rich Fibrin) Origin, Application, Region” and Global Forecast 2018-2025.
The global platelet-rich plasma market is expected to reach USD 197.27 Million in 2017 to USD 540.31 Million by 2025 at a CAGR of 12.21% during the forecast period from 2018-2025. Increasing geriatric population, rising incidence of sports and orthopedic injuries, rise in number of cosmetic surgical procedures and increase in awareness regarding PRP therapies are driving the growth of the market. The type segment is classified into pure platelet-rich plasma, leukocyte-rich platelet-rich plasma, and pure platelet-rich fibrin. The pure platelet-rich plasma segment accounted for the largest share in 2017. This is attributed to widespread use in various applications and rich content of platelets. Origin segment is divided into autologous platelet-rich plasma, allogeneic platelet-rich plasma, and homologous platelet-rich plasma. The autologous segment accounted for the largest market share in 2017. Ease of production and less threat of disease transmission is contributing to the growth of the segment.
Increasing geriatric population, rising incidence of sports and orthopedic injuries are expected to enhance the growth of the segment. In addition, Adoption of this therapy in cosmetic industry is boosting the growth of the market. Lack of awareness may restrict the growth of the market. However, various research activities in this field are driving the growth of the market in forecast period.
About the report:
The global platelet-rich plasma market is analysed on the basis of value (USD Billion), volume (K Units), export (K Units), and import (K Units). All the segments have been analyzed on global, regional and country basis. The study includes the analysis of more than 30 countries for each segment. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The study includes porter’s five forces model, attractiveness analysis, raw material analysis, and competitor position grid analysis.
Customization of the Report:
The report can be customized as per client requirements. For further queries, you can contact us on firstname.lastname@example.org or +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.
- CDN Newswire